Ardelyx ARDX Accrued gross to net revenue liabilities
Accrued gross to net revenue liabilities at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept ardx:AccruedGrossToNetRevenueLiabilities.
The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's accrued gross to net revenue liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's accrued gross to net revenue liabilities?
- Ardelyx (ARDX) reported accrued gross to net revenue liabilities of $30.27M in Q4 2025.
- How has Ardelyx's accrued gross to net revenue liabilities changed year-over-year?
- Ardelyx's accrued gross to net revenue liabilities increased by 199.4% year-over-year, from $10.11M to $30.27M.
- What does accrued gross to net revenue liabilities mean?
- The estimated liability for rebates, chargebacks, discounts, and returns associated with product sales that have been recognized but not yet settled. This metric is critical for biotechnology companies to accurately reflect net revenue by accounting for the difference between gross sales and the actual cash expected to be collected. High levels may indicate aggressive sales strategies or significant contractual obligations to payers and distributors.